FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

397192001: Fluticasone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1765110017 Fluticasone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776880018 Fluticasone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54571000195115 fluticasone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
812921000172115 fluticasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68941000195116 Fluticason de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluticasone (substance) Is a Anti-inflammatory agent false Inferred relationship Some
Fluticasone (substance) Is a corticostéroïde pour administration pulmonaire false Inferred relationship Some
Fluticasone (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Androgen receptor agonist (disposition) false Inferred relationship Some
Fluticasone (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadal hormone false Inferred relationship Some
Fluticasone (substance) Is a Androstane true Inferred relationship Some
Fluticasone (substance) Is a Fluorinated corticosteroid true Inferred relationship Some
Fluticasone (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Fluticasone (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Fluticasone propionate (substance) Is a False Fluticasone (substance) Inferred relationship Some
Product containing fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone adverse reaction Causative agent (attribute) True Fluticasone (substance) Inferred relationship Some 1
Allergy to fluticasone (finding) Causative agent (attribute) False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone furoate (substance) Is a False Fluticasone (substance) Inferred relationship Some
Fluticasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Allergy to fluticasone (finding) Causative agent (attribute) True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone and vilanterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone and vilanterol in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Product containing fluticasone and umeclidinium and vilanterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone and umeclidinium and vilanterol in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluticasone (substance) Inferred relationship Some
Fluticasone furoate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Fluticasone (substance) Inferred relationship Some
Fluticasone propionate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Fluticasone (substance) Inferred relationship Some
Product containing fluticasone in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone- and umeclidinium- and vilanterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone- and vilanterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Product containing only fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing only fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Product containing only fluticasone and umeclidinium and vilanterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone and vilanterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone and salmeterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Fluticasone and vilanterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing only fluticasone in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing only fluticasone in nasal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone and umeclidinium and vilanterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Product containing azelastine and fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Azelastine and fluticasone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Azelastine and fluticasone only product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Azelastine- and fluticasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 2
Fluticasone and formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone- and formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone- and formoterol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1
Fluticasone and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fluticasone (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start